Trademarkia Logo

Canada

C$
CAPSULE DESIGN
REGISTERED

on 1 Nov 2024

Last Applicant/ Owned by

MERCK SHARP & DOHME B.V.

Waarderweg 39NL-2031 BN HAARLEM

NL

Serial Number

2158587 filed on 10th Dec 2021

Registration Number

TMA1266821 registered on 1st Nov 2024

Registration expiry Date

10th Dec 2031

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

CAPSULE DESIGN

Trademark usage description

pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gast Read More

Vienna Information


26 . 7 . 5

Circles or ellipses with one or more other quadrilateralsCercles ou ellipses avec un ou plusieurs quadrilatères

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

25 . 5 . 1

Backgrounds divided into two, verticallyFonds partagés en deux dans le sens vertical

26 . 2 . 7

Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 2 . 24

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfacesSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses avec surface ou partie de la surface foncée

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 12

Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

19 . 13 . 1

Medical or surgical apparatus, instruments or utensils, prostheses, medicinesAppareils, instruments ou ustensiles de chirurgie ou de médecine, prothèses, médicaments

19 . 13 . 21

Phials, capsules, pills, tablets, suppositoriesAmpoules, capsules, pilules, tablettes, suppositoires

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 6

White, grey, silverBlanc, gris, argent

Classification Information


Class [005]
Pharmaceutical preparations and substances for the prevention and treatment of bone, cardiovascular, hematological, hepatological, immunological, gastrointestinal, musculoskeletal, nephrological, oncological, ophthalmic, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections, parasitic skin infections, psoriasis, eczema, and dermatitis; Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the endocrine system, namely, glucagonoma, growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations and substances for the prevention and treatment of genitourinary diseases and disorders, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; Pharmaceutical preparations and substances for the prevention and treatment of gynecological diseases and disorders, namely amenorrhoea, dysmenorrheal and diseases and disorders relating to sexual reproduction and fertility; Pharmaceutical preparations and substances for the prevention and treatment of metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, arthritis, obesity and hypothyroidism; Pharmaceutical preparations and substances for the prevention and treatment of neurological diseases and disorders, namely, schizophrenia pain, neuropathic pain; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, psychoses and bipolar disorders; Pharmaceutical preparations and substances for the prevention and treatment of Respiratory Syncytial Virus (RSV); Pharmaceutical preparations substances for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, namely, dermatitis, skin pigmentation diseases, psoriasis, acne, rosacea, ichthyosis, urticaria and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; Human vaccine preparations; Inhaled pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2158587

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 29th Mar 2023
Search Recorded
Submitted for opposition 20
on 29th Mar 2023
Examiner's First Report
Submitted for opposition 223
on 29th Mar 2023
Total Provisional Refusal
Submitted for opposition 256
on 7th Nov 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 25th Apr 2022
Agent Changed
Submitted for opposition 257
on 6th Jan 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 5th Jan 2022
Created
Submitted for opposition 31
on 5th Jan 2022
Formalized
Submitted for opposition 228
on 10th Dec 2021
International Registration
Submitted for opposition 30
on 10th Dec 2021
Filed